Clinical Trials Logo

Hemifacial Spasm clinical trials

View clinical trials related to Hemifacial Spasm.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT04645277 Recruiting - Clinical trials for Magnetic Resonance Imaging

Magnetic Resonance Imaging Study on Patients With Hemifacial Spasm

MRI-HFS
Start date: January 1, 2021
Phase:
Study type: Observational [Patient Registry]

Up to now, multiplanar reconstruction (MPR) has been widely used to detect the neurovascular compressions (NVC) on the patients with hemifacial spasm (HFS). However, due to lack of stereoscopic vision, this traditional method sometimes can not meet the requirement on identifying the details of NVC, especially when the aberrant vessels turn out to be veins not arteries. The three dimensional analytic techniques, such as curved planar reconstruction (CPR) and magnetic resonance virtual endoscopy (MRVE), may be helpful to improve the sensitivity and specificity on the demonstration of NVC with stereo and dynamic views, so as to assist the design of the surgical plan. Furthermore, the frequent finding of NVC on MRI studies of asymptomatic patients incited the creation of several strict criteria for the imaging diagnosis of NVC: the vessel must cross perpendicular to the long axis of the nerve, the nerve must be deviated or indented at the root entry zoon (REZ) by the vessel. Alternatively, morphological measurement of the nerve may correlate with the severity of facial spasm due to atrophy of the nerve in most cases of HFS, and is likely secondary to the micro-structural abnormalities, such as axonal loss, demyelination, collagen deposition, etc. In this study, cross-sectional area (CSA) and volume (V) of the cisternal facial nerve will be assessed to determine whether it can be a useful biomarker for predicting the degree of HFS.

NCT ID: NCT03306940 Recruiting - Hemifacial Spasm Clinical Trials

Botulinum Toxin A in the Treatment of Hemifacial Spasm

BTATHS
Start date: October 2, 2017
Phase: N/A
Study type: Interventional

Hemifacial spasm patients who received botulinum toxin A injection were divided into two groups. Group A received unilateral injection while group B received bilateral injection. Patients completed follow-up A researcher record facial videos and analyzed facial symmetry and completed 3 scales.